Politics ❯ Trump Administration

Health Policy

Research Funding Public Health Drug Pricing Initiatives Regulatory Changes Public Health Funding Public Health Decisions Government Agencies NIH Funding Federal Agencies Public Health Programs Agency Operations Agency Oversight Research Grants Health Initiatives Drug Regulation Nomination Process Department Restructuring Transparency Issues Federal Budget Cuts Funding Cuts Workforce Reduction Public Health Initiatives Food Regulation LGBTQ Rights Pharmaceutical Regulations CDC Reforms COVID-19 Vaccine Recommendations Advisory Committees Vaccine Advisory Panel Department of Health and Human Services FDA Actions Drug Policy Robert F. Kennedy Jr. FDA Regulations Medical Research Funding Agency Dynamics Vaccine Skepticism Vaccine Controversy CDC Leadership COVID-19 Vaccine Policy Personnel Management CDC Public Health Agencies Leadership Changes Foreign Aid Policy Vaccine Controversies Drug Advertising Federal Communication COVID-19 Response Vaccine Opposition State Lawsuits Public Statements Subsidies Vaccine Policy Food Regulations Secretary of Health and Human Services Visa Guidelines Regulatory Agencies Pandemic Preparedness Fluoride Controversy NIH Leadership Vaccination Controversy

Kennedy Says Evidence Is Not Sufficient to Link Tylenol to Autism

His revised message comes during regulatory review plus fresh litigation.

Belgium Disputes U.S. Claim of Destroying $10 Million in Contraceptives

FDA Sends Mass Warnings, Seeks to End 1997 Drug Ad Rule After White House Directive

NIH Whistle-Blowers Allege Vaccine Skepticism and Politicized Grantmaking at the Top

GAO Finds HHS Violated Impoundment Control Act in Head Start Funding Delays

RFK Jr. Weighs New Limits on TV Drug Advertising

RFK Jr. Reconstitutes ACIP as CDC, FDA Narrow COVID-19 Vaccine Recommendations